Launch of new unique needle

Vitrolife launched a new needle for the collection of human oocytes at ESHRE, the largest congress of the year within IVF.
“The needle combines the good properties of our previous needles with a new way of designing the front part and tip, so that the patient will experience less discomfort. We are extremely happy about the positive response and attention that this needle received at the congress,” says Nils Sellbom, Sales Director at Vitrolife.

At the annual European reproduction congress ESHRE in the beginning of July a new needle, Swemed Sense™, was launched. The needle is designed with a thinner front part and tip so as to minimize tissue damage, bleeding and pain. As the body of the needle has a larger diameter, the ability to collect the oocytes from the woman is not reduced, however. The procedure is just as fast as when a thicker needle is used. A patent application has been submitted for Swemed Sense™. It is estimated that the market for needles used in follicle aspiration to collect oocytes for IVF amounts to approximately 50 million Euros.




July 14, 2008
Kungsbacka, Sweden

Magnus Nilsson
CEO








Queries should be addressed to:
Magnus Nilsson, CEO, phone +46 31 721 80 00 or +46 708 22 80 61.
Anna Ahlberg, CFO, phone +46 31 721 80 13 or +46 708 22 80 13.